Menu
← Oncology Approval Tracker
FDA DECISION ·
Phesgo
pertuzumab + trastuzumab + hyaluronidase-zzxf · Genentech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
With chemotherapy before surgery for HER2-positive locally advanced, inflammatory or early breast cancer over 2 cm or node positive; with chemotherapy after surgery for high-risk HER2-positive early disease; and with docetaxel for HER2-positive metastatic disease without prior HER2-directed treatment or chemotherapy in the metastatic setting.
LAMPGEN ANALYSIS
Why it matters
Combined two HER2-directed antibodies into one subcutaneous administration.
What research teams should watch
Train on loading and maintenance doses and preserve cardiac monitoring and post-injection observation.
PRIMARY RECORDS